ATE375362T1 - Von cyclophilin b abstammende tumorantigen- peptide - Google Patents
Von cyclophilin b abstammende tumorantigen- peptideInfo
- Publication number
- ATE375362T1 ATE375362T1 AT99926783T AT99926783T ATE375362T1 AT E375362 T1 ATE375362 T1 AT E375362T1 AT 99926783 T AT99926783 T AT 99926783T AT 99926783 T AT99926783 T AT 99926783T AT E375362 T1 ATE375362 T1 AT E375362T1
- Authority
- AT
- Austria
- Prior art keywords
- tumor antigen
- antigen peptides
- peptides derived
- cyclophilins
- cyclophilin
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 6
- 239000000427 antigen Substances 0.000 title abstract 4
- 108091007433 antigens Proteins 0.000 title abstract 4
- 102000036639 antigens Human genes 0.000 title abstract 4
- 102100040283 Peptidyl-prolyl cis-trans isomerase B Human genes 0.000 title 1
- 108010048032 cyclophilin B Proteins 0.000 title 1
- 108010044156 peptidyl-prolyl cis-trans isomerase b Proteins 0.000 title 1
- 102000001493 Cyclophilins Human genes 0.000 abstract 4
- 108010068682 Cyclophilins Proteins 0.000 abstract 4
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17844998 | 1998-06-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE375362T1 true ATE375362T1 (de) | 2007-10-15 |
Family
ID=16048723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99926783T ATE375362T1 (de) | 1998-06-25 | 1999-06-24 | Von cyclophilin b abstammende tumorantigen- peptide |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7041297B1 (de) |
| EP (1) | EP1090924B8 (de) |
| JP (1) | JP4413429B2 (de) |
| KR (1) | KR100653590B1 (de) |
| CN (1) | CN1318447C (de) |
| AT (1) | ATE375362T1 (de) |
| AU (1) | AU749544B2 (de) |
| CA (1) | CA2331761A1 (de) |
| DE (1) | DE69937294T2 (de) |
| ES (1) | ES2294844T3 (de) |
| HK (1) | HK1067645A1 (de) |
| ID (1) | ID27788A (de) |
| NZ (1) | NZ508996A (de) |
| TW (1) | TWI228128B (de) |
| WO (1) | WO1999067288A1 (de) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7105306B1 (en) * | 2000-08-10 | 2006-09-12 | Trustees Of The University Of Pennsylvania | Methods and compositions for modulating somatolactogenic functions |
| EP1212078B1 (de) * | 1999-09-10 | 2005-06-22 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Ant-1 als therapeutisches zielmolekül |
| AU3105801A (en) * | 2000-01-24 | 2001-07-31 | Trustees Of Tufts College | Tetracycline compounds for treatment of cryptosporidium parvum related disorders |
| US6642270B2 (en) * | 2000-05-15 | 2003-11-04 | Paratek Pharmaceuticals, Inc. | 7-substituted fused ring tetracycline compounds |
| US20020128238A1 (en) * | 2000-06-16 | 2002-09-12 | Nelson Mark L. | 7-phenyl-substituted tetracycline compounds |
| WO2003055441A2 (en) * | 2001-08-02 | 2003-07-10 | Paratek Pharmaceuticals, Inc. | Medicaments |
| EP2014679B1 (de) | 2002-09-12 | 2010-05-05 | Oncotherapy Science, Inc. | KDR-Peptide und diese enthaltende Impfstoffe |
| CA2538300A1 (en) * | 2003-09-22 | 2005-03-31 | Green Peptide Co., Ltd. | Prognosis in cancer patients vaccinated with a cancer antigen peptide-associated agent |
| TWI261038B (en) * | 2004-08-11 | 2006-09-01 | Bo-Cheng Chen | Bicycle gear-shifting handgrip |
| EP2301912A3 (de) | 2004-10-25 | 2012-07-11 | Paratek Pharmaceuticals, Inc. | 4-Aminotetracycline und Verfahren zu ihrer Verwendung |
| AU2007244153C1 (en) | 2006-05-01 | 2011-09-29 | Hitachi Chemical Company, Ltd. | Prostasin partial peptide and anti-prostasin antibody |
| US8440646B1 (en) | 2006-10-11 | 2013-05-14 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for treatment of Bacillus anthracis infections |
| JP2010512730A (ja) | 2006-12-13 | 2010-04-30 | オンコセラピー・サイエンス株式会社 | 肺癌の腫瘍マーカーおよび治療標的としてのｔｔｋ |
| KR101493775B1 (ko) | 2007-02-16 | 2015-02-16 | 온코세라피 사이언스 가부시키가이샤 | 맥락막 신생혈관용 백신 치료 |
| TWI434853B (zh) | 2007-04-11 | 2014-04-21 | Oncotherapy Science Inc | 腫瘤血管內皮標誌８胜肽及包含此胜肽之疫苗 |
| WO2009028581A1 (en) | 2007-08-24 | 2009-03-05 | Oncotherapy Science, Inc. | Cancer-related genes, cdca5, epha7, stk31 and wdhd1 |
| US9102715B2 (en) | 2007-09-18 | 2015-08-11 | Green Peptide Co., Ltd. | CTL inducer composition |
| MY153749A (en) | 2007-11-29 | 2015-03-13 | Actelion Pharmaceuticals Ltd | Phosphonic acid derivates and their use as p2y12 receptor antagonists |
| TWI526219B (zh) | 2008-06-19 | 2016-03-21 | 腫瘤療法 科學股份有限公司 | Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗 |
| DE102008060549A1 (de) | 2008-12-04 | 2010-06-10 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung |
| TWI539160B (zh) | 2008-12-05 | 2016-06-21 | 腫瘤療法 科學股份有限公司 | Ｗｄｒｐｕｈ抗原決定位胜肽以及含此胜肽之疫苗 |
| TWI469791B (zh) | 2009-02-18 | 2015-01-21 | Oncotherapy Science Inc | Ｆｏｘｍ１胜肽以及含此胜肽之疫苗 |
| BRPI1009301A2 (pt) | 2009-03-18 | 2016-03-08 | Oncotherapy Science Inc | peptídeos neil 3 e vacinas incluindo os mesmos |
| TWI507204B (zh) | 2009-05-26 | 2015-11-11 | Oncotherapy Science Inc | Ｃｄｃ４５ｌ胜肽與含此胜肽之疫苗 |
| TW201136604A (en) | 2009-12-14 | 2011-11-01 | Oncotherapy Science Inc | TMEM22 peptides and vaccines including the same |
| US8933014B2 (en) | 2010-03-11 | 2015-01-13 | Oncotherapy Science, Inc. | HJURP peptides and vaccines including the same |
| US9725490B2 (en) | 2011-07-29 | 2017-08-08 | Tokushima University | ERAP1-derived peptide and use thereof |
| CN103732743B (zh) | 2011-08-12 | 2017-03-15 | 肿瘤疗法科学股份有限公司 | Mphosph1肽及包含它们的疫苗 |
| KR102020491B1 (ko) | 2011-10-28 | 2019-09-10 | 온코세라피 사이언스 가부시키가이샤 | Ｔｏｐｋ 펩티드 및 이를 포함하는 백신 |
| WO2014010231A1 (en) | 2012-07-10 | 2014-01-16 | Oncotherapy Science, Inc. | Kif20a epitope peptides for th1 cells and vaccines containing the same |
| JP6255594B2 (ja) | 2012-07-10 | 2018-01-10 | オンコセラピー・サイエンス株式会社 | Ｔｈ１細胞のＬＹ６Ｋエピトープペプチドおよびこれを含有するワクチン |
| MX362912B (es) | 2012-09-11 | 2019-02-22 | Oncotherapy Science Inc | Péptidos ube2t y vacunas que incluyen los mismos. |
| TWI658049B (zh) | 2013-03-12 | 2019-05-01 | 腫瘤療法 科學股份有限公司 | Ｋｎｔｃ２胜肽及含此胜肽之疫苗 |
| PL3061771T3 (pl) | 2013-10-21 | 2020-10-19 | Taiho Pharmaceutical Co., Ltd. | Nowy peptyd o czterech połączonych epitopach dla ctl |
| US10576102B2 (en) | 2014-08-04 | 2020-03-03 | Oncotherapy Science, Inc. | KOC1-derived peptide and vaccine including same |
| EP3178839B1 (de) | 2014-08-04 | 2023-10-04 | Oncotherapy Science, Inc. | Cdca1-abgeleitetes peptid und impfstoff damit |
| KR20170030649A (ko) | 2014-08-04 | 2017-03-17 | 온코세라피 사이언스 가부시키가이샤 | Urlc10-유래 펩티드 및 이를 포함하는 백신 |
| WO2017061523A1 (ja) | 2015-10-08 | 2017-04-13 | オンコセラピー・サイエンス株式会社 | Ｆｏｘｍ１由来ペプチドおよびそれを含むワクチン |
| MA53026A (fr) | 2018-06-29 | 2021-05-05 | Taiho Pharmaceutical Co Ltd | Agent antitumoral et sa méthode d'évaluation |
| TW202023581A (zh) | 2018-08-02 | 2020-07-01 | 日商腫瘤療法 科學股份有限公司 | 來自cdca1的胜肽及含有此的疫苗 |
| WO2020111167A1 (ja) | 2018-11-30 | 2020-06-04 | 国立大学法人徳島大学 | Ｂｉｇ３－ｐｈｂ２相互作用阻害ｐｈｂ２由来ペプチドを含む乳がん治療薬 |
| EP4082563A4 (de) | 2019-12-26 | 2024-02-28 | Taiho Pharmaceutical Co., Ltd. | Mittel zur postoperativen adjuvanten therapie |
| CN115078727A (zh) * | 2022-07-13 | 2022-09-20 | 首都医科大学附属北京胸科医院 | 一种预测癌症免疫治疗效果的标志物、试剂盒与应用 |
| DE102022118517A1 (de) | 2022-07-25 | 2024-01-25 | Dennis Reitmeir | Liegestützvorrichtung mit drehbaren Griffeinheiten |
| CN115372618B (zh) * | 2022-09-19 | 2025-01-14 | 首都医科大学附属北京胸科医院 | 一种检测蛋白标志物水平的试剂在制备用于评估肿瘤治疗效果的诊断产品中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0326067A3 (de) | 1988-01-26 | 1991-04-17 | The Du Pont Merck Pharmaceutical Company | Verwendung von Cyclophylin als Entzündungshemmer und Immunmodulator |
| ATE342730T1 (de) * | 1992-08-07 | 2006-11-15 | Pharmexa Inc | Hla bindepeptide und ihre verwendungen |
| JPH09151200A (ja) * | 1995-09-29 | 1997-06-10 | Ajinomoto Co Inc | ヒト胃癌に対する免疫応答を誘導できるペプチド及び該ペプチドを含むヒト胃癌治療、予防剤 |
| US5840839A (en) * | 1996-02-09 | 1998-11-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
-
1999
- 1999-06-24 CN CNB998098566A patent/CN1318447C/zh not_active Expired - Lifetime
- 1999-06-24 KR KR1020007014760A patent/KR100653590B1/ko not_active Expired - Lifetime
- 1999-06-24 DE DE69937294T patent/DE69937294T2/de not_active Expired - Lifetime
- 1999-06-24 AU AU43926/99A patent/AU749544B2/en not_active Ceased
- 1999-06-24 ES ES99926783T patent/ES2294844T3/es not_active Expired - Lifetime
- 1999-06-24 NZ NZ508996A patent/NZ508996A/en unknown
- 1999-06-24 WO PCT/JP1999/003360 patent/WO1999067288A1/ja active IP Right Grant
- 1999-06-24 JP JP2000555939A patent/JP4413429B2/ja not_active Expired - Lifetime
- 1999-06-24 EP EP99926783A patent/EP1090924B8/de not_active Expired - Lifetime
- 1999-06-24 CA CA002331761A patent/CA2331761A1/en not_active Abandoned
- 1999-06-24 ID IDW20002735A patent/ID27788A/id unknown
- 1999-06-24 US US09/720,469 patent/US7041297B1/en not_active Expired - Fee Related
- 1999-06-24 AT AT99926783T patent/ATE375362T1/de not_active IP Right Cessation
- 1999-06-25 TW TW088110697A patent/TWI228128B/zh not_active IP Right Cessation
-
2004
- 2004-12-03 HK HK04109605A patent/HK1067645A1/xx not_active IP Right Cessation
-
2005
- 2005-09-16 US US11/227,238 patent/US7368107B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU4392699A (en) | 2000-01-10 |
| WO1999067288A1 (fr) | 1999-12-29 |
| US7368107B2 (en) | 2008-05-06 |
| AU749544B2 (en) | 2002-06-27 |
| TWI228128B (en) | 2005-02-21 |
| EP1090924A1 (de) | 2001-04-11 |
| EP1090924B1 (de) | 2007-10-10 |
| EP1090924A4 (de) | 2002-07-10 |
| CN1318447C (zh) | 2007-05-30 |
| CA2331761A1 (en) | 1999-12-29 |
| HK1067645A1 (en) | 2005-04-15 |
| US7041297B1 (en) | 2006-05-09 |
| US20060008463A1 (en) | 2006-01-12 |
| JP4413429B2 (ja) | 2010-02-10 |
| DE69937294T2 (de) | 2008-07-03 |
| KR20010053180A (ko) | 2001-06-25 |
| ID27788A (id) | 2001-04-26 |
| WO1999067288A9 (fr) | 2000-03-30 |
| CN1525980A (zh) | 2004-09-01 |
| EP1090924B8 (de) | 2007-11-21 |
| NZ508996A (en) | 2003-09-26 |
| DE69937294D1 (de) | 2007-11-22 |
| ES2294844T3 (es) | 2008-04-01 |
| KR100653590B1 (ko) | 2006-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE375362T1 (de) | Von cyclophilin b abstammende tumorantigen- peptide | |
| BR9907259A (pt) | Compostos para terapia e diagnóstico de câncer de pulmão e processos para o seu uso | |
| EP0570916A3 (de) | Menschliches rekombinantes Serum-Albumin, Verfahren zur dessen Herstellung und diese enthaltende pharmazeutischen Präparate. | |
| IL125590A (en) | Peptide immunogens, process for their preparation and use thereof as vaccines against allergies | |
| NZ516381A (en) | Lung tumor proteins in the therapy and diagnosis of lung cancer | |
| WO1998037093A3 (en) | Compounds for immunotherapy of prostate cancer and methods for their use | |
| WO1999033869A3 (en) | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use | |
| AU2001235006A1 (en) | Prophylactic and therapeutic monoclonal antibodies | |
| WO2000029574A3 (en) | Inflammation-associated genes | |
| ATE295423T1 (de) | Phosphodiesterase 8 | |
| SE9802937D0 (sv) | Novel compounds | |
| NZ510154A (en) | A tumour antigen protein and gene therefor, tumour antigen peptides and derivatives thereof in medicaments and prophylactics | |
| WO2001029220A3 (en) | Mage-a12 antigenic peptides and uses thereof | |
| EP1364657A4 (de) | Mittel gegen tumoren in hämatopoetischen organen | |
| ATE310828T1 (de) | Implantat und vektor zur behandlung von erworbenen krankheiten | |
| DE69700983D1 (de) | Ligandgerichtete enzyme-prodrug therapie | |
| NZ331398A (en) | Tumor rejection antigens presented by hla-b44 molecules, and uses thereof | |
| WO2000052045A3 (en) | Mage-3 derived immunogenic peptides presented by mhc of class ii and the use thereof | |
| CA2139518A1 (en) | Antigenic regions of tlp complexes and antibodies against the same | |
| EP1103561A4 (de) | Hla-a2 beschränktes tumorantigen-peptid, das von sart-1 abstammt | |
| HUP0200679A2 (en) | Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients | |
| EA199801032A1 (ru) | Белки zona pellucida для контрацепции | |
| WO2000073450A3 (en) | Cytoskeleton-associated proteins | |
| CY1108790T1 (el) | Συνθεσεις για τη θεραπεια και διαγνωση ωοθηκικου καρκινου | |
| EP2003201A3 (de) | Verbindungen und Verfahren für Therapie und Diagnose von Lungenkrebs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |